Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

200.48
-2.8600-1.41%
Post-market: 200.480.00000.00%16:29 EDT
Volume:3.61M
Turnover:721.99M
Market Cap:10.30B
PE:31.76
High:201.72
Open:200.90
Low:196.87
Close:203.34
52wk High:217.12
52wk Low:149.09
Shares:51.40M
Float Shares:51.40M
Volume Ratio:1.98
T/O Rate:7.03%
Dividend:0.35
Dividend Rate:0.17%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.27
PE(LYR):5.67

Loading ...

Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)

TIPRANKS
·
Oct 02

Vertex Minerals lodges 2026 corporate governance statement with ASX

TIPRANKS
·
Oct 02

Sino Biopharmaceutical Stock Falls 2.3% in Hong Kong, Underperforms Competitors

Dow Jones
·
Oct 02

Quantum Computing is Having a Moment. What to Know About the Hottest Sector After AI.

Dow Jones
·
Oct 02

Regeneron Pharmaceuticals, Inc. : Jefferies Raises Target Price to $930 from $870

THOMSON REUTERS
·
Oct 02

More Upside Awaits for Gilead Sciences Stock. Stay Invested.

Dow Jones
·
Oct 02

Vortex Energy Expands Saskatchewan Portfolio with Meadows Project Acquisition

TIPRANKS
·
Oct 02

Vertex adds AI-focused independent director to board

TIPRANKS
·
Oct 02

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

TIPRANKS
·
Oct 02

Amgen Inc Stock (AMGN) Closed Down by 3.38% on Oct 1: What Investors Need To Know

TradingKey
·
Oct 02

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Oct 02

Sector Update: Healthcare

MT Newswires Live
·
Oct 02

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.21% on Oct 1: What Investors Need To Know

TradingKey
·
Oct 02

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-01

Reuters
·
Oct 02

Sector Update: Healthcare

MT Newswires Live
·
Oct 02

Regeneron price target raised to $930 from $870 at Jefferies

TIPRANKS
·
Oct 02

Amgen’s Pediatric Psoriasis Study in Japan Wraps Up, Setting the Stage for Otezla Growth

TIPRANKS
·
Oct 02

Expanded Sanofi agreement particularly favorable for Regeneron, says TD Cowen

TIPRANKS
·
Oct 02

Walt Disney, Amgen Share Losses Lead Dow's 150-Point Fall

Dow Jones
·
Oct 02

Regeneron says COURAGE trial confirms trevogrumab prevents muscle loss

TIPRANKS
·
Oct 01